EGFR and non-small cell lung carcinoma: It has been demonstrated that NSCLC-associated EGFR mutants appear to have impaired interactions with c-CBL, causing defective ubiquitination and degradation of EGFR, resulting in prolonged EGFR signaling [47, 48].